-
vybe urgent care Re-opens in Bensalem
Post on 7/21/20
-
GlaxoSmithKline Buys Stake in German Coronavirus Vaccine Developer CureVac
Post on 7/21/20
-
Dividend Aristocrat Johnson & Johnson Declares Fresh Dividend; Yield Is 2.7%
Post on 7/21/20
-
U.K. Secures 30 Million Doses of Coronavirus Vaccine Candidate From Pfizer and BioNTech
Post on 7/21/20
-
Teva Putting Its Troubles Behind, Why The Stock Is Cheap And I'm Long
Post on 7/21/20
-
Teligent Completes Series C Convertible Note Financing
Post on 7/21/20
-
OPKO Health's BioReference Laboratories Awarded Commercial Surge Capacity Testing for COVID-19 Emergency Response Contract
Post on 7/20/20
-
CytoSorbents Corp. Proposes $40M Public Offering of Common Stock
Post on 7/20/20
-
CytoSorbents Provides Corporate Update
Post on 7/20/20
-
Proper Nutrition, Starting with Daily Celery Juice, is Key to Building Healthy Immune System
Post on 7/20/20
-
PTC Therapeutics To Monetize a Portion of the Risdiplam Royalty Stream for $650 Million
Post on 7/20/20
-
Johnson & Johnson: A Core Dividend Growth Stock With Risks
Post on 7/20/20
-
Johnson & Johnson: This Dividend Aristocrat Is Ready To Break Out
Post on 7/20/20
-
Better Buy: Rite Aid vs. Walgreens
Post on 7/20/20
-
Outlook Therapeutics Closes $1.0M Private Placement
Post on 7/19/20
-
Nabriva Therapeutics Enters into Exclusive Agreement to Promote and Distribute SIVEXTRO in the U.S.
Post on 7/18/20
-
Ambu Receives FDA Clearance for its Sterile, Single-use Duodenoscope
Post on 7/17/20
-
Epion Health Recognized as one of the Best Places to Work in Healthcare Again in 2020
Post on 7/17/20
-
Amicus Therapeutics Secures $400 Million Non-Dilutive Debt Financing
Post on 7/17/20
-
Dow Jones Slumps as Johnson & Johnson Boosts Outlook, Apple and Cisco Stocks Head Lower
Post on 7/17/20
-
Johnson & Johnson's Revenue and Earnings Slipped in the Second Quarter
Post on 7/17/20
-
Should Inovio's Lawsuits Worry Investors?
Post on 7/17/20
-
Aramark Named One of the Best Places to Work for Disability Inclusion
Post on 7/16/20
-
SCYNEXIS Announces One-for-Ten Reverse Stock Split
Post on 7/16/20
-
Imvax Raises $112M In Series C
Post on 7/16/20
Philadelphia
